<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC6224342/results/search/disease/results.xml">
  <result pre="some AIBD are associated with malign tumors such as paraneoplastic" exact="pemphigus" post="and anti-laminin 332 mucous membrane pemphigoid. This review presents"/>
  <result pre="the art diagnosis of these disorders. autoantibody biochip immunofluorescence ELISA" exact="pemphigus" post="pemphigoid epidermolysis bullosa acquisita dermatitis herpetiformis fig-count: table-count: equation-count:"/>
  <result pre="diagnosis of these disorders. autoantibody biochip immunofluorescence ELISA pemphigus pemphigoid" exact="epidermolysis bullosa" post="acquisita dermatitis herpetiformis fig-count: table-count: equation-count: ref-count: page-count: word-count:"/>
  <result pre="disorders. autoantibody biochip immunofluorescence ELISA pemphigus pemphigoid epidermolysis bullosa acquisita" exact="dermatitis" post="herpetiformis fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction Autoimmune"/>
  <result pre="keratinocytes ( 1, 2). A special type of AIBD is" exact="dermatitis" post="herpetiformis, with autoantibodies directed against the tissue and epidermal"/>
  <result pre="patients/million/year ( 9, 14). Generally, PV is more common than" exact="pemphigus" post="foliaceus (PF), with ratios ranging from 4:1 to 9:1"/>
  <result pre="around 2,000 with MMP ( 18). Historical background The term" exact="pemphigus" post="was first used by Hippocrates in 460–370 B.C. ("/>
  <result pre="Hippocrates in 460–370 B.C. ( 19). However, the differentiation between" exact="pemphigus" post="and BP was first made by Walter Lever in"/>
  <result pre="detection of autoantibodies in serum and skin were reported for" exact="pemphigus" post="and BP ( 21, 22), providing milestones for the"/>
  <result pre="binding to type VII collagen and can been seen in" exact="epidermolysis bullosa" post="acquisita (EBA), n-serration is found in all other pemphigoid"/>
  <result pre="on direct immunofluorescence (DIF) microscopy of a perilesional biopsy. BP," exact="bullous pemphigoid;" post="EBA, epidermolysis bullosa acquisita; MMP, mucous membrane pemphigoid; PF,"/>
  <result pre="(DIF) microscopy of a perilesional biopsy. BP, bullous pemphigoid; EBA," exact="epidermolysis bullosa" post="acquisita; MMP, mucous membrane pemphigoid; PF, pemphigus foliaceus; PNP,"/>
  <result pre="pemphigoid; EBA, epidermolysis bullosa acquisita; MMP, mucous membrane pemphigoid; PF," exact="pemphigus" post="foliaceus; PNP, paraneoplastic pemphigus; PV, pemphigus vulgaris; *may be"/>
  <result pre="mucous membrane pemphigoid; PF, pemphigus foliaceus; PNP, paraneoplastic pemphigus; PV," exact="pemphigus" post="vulgaris; *may be combined with linear deposition. Figure 2"/>
  <result pre="with linear deposition. Figure 2 Clinical and immunopathological characteristics in" exact="bullous pemphigoid" post="(BP, left), pemphigus vulgaris (PV, middle), and epidermolysis bullosa"/>
  <result pre="2 Clinical and immunopathological characteristics in bullous pemphigoid (BP, left)," exact="pemphigus" post="vulgaris (PV, middle), and epidermolysis bullosa acquisita (EBA, right)."/>
  <result pre="in bullous pemphigoid (BP, left), pemphigus vulgaris (PV, middle), and" exact="epidermolysis bullosa" post="acquisita (EBA, right). Figure 3 n-serrated (left) and u-serrated"/>
  <result pre="immunofluorescence microscopy. While an u-serrated pattern is exclusively seen in" exact="epidermolysis bullosa" post="acquisita, an n-serrated pattern can be detected in all"/>
  <result pre="pattern can be detected in all other pemphigoid diseases. In" exact="dermatitis" post="herpetiformis, DIF microscopy reveals granular deposition of IgA at"/>
  <result pre="AIBD including monkey, rabbit, guinea pig, and human esophagus (for" exact="pemphigus" post="and pemphigoid diseases), monkey and rat bladder (for paraneoplastic"/>
  <result pre="esophagus and human split skin. On monkey esophagus, autoantibodies in" exact="pemphigus" post="reveal intercellular labeling of the epithelium and linear staining"/>
  <result pre="2). Sensitivities of 90% and 73.2% have been reported for" exact="pemphigus" post="and BP, respectively ( 41, 43). In dermatitis herpetiformis,"/>
  <result pre="reported for pemphigus and BP, respectively ( 41, 43). In" exact="dermatitis" post="herpetiformis, IgA binds to the endomysium. The tissue substrate"/>
  <result pre="the serological detection of autoantibodies. Dsc, desmocollin; Dsg, desmoglein; EBA," exact="epidermolysis bullosa" post="acquisita; * commercial assays are available; ** available by"/>
  <result pre="autoantibodies against envoplakin has been developed (Euroimmun) ( 60). For" exact="dermatitis" post="herpetiformis, ELISA systems for the detection of coeliac-specific gliadin"/>
  <result pre="reactivity was only found in about 3% of around 400" exact="pemphigus" post="sera, using a BIOCHIP® mosaic containing recombinant forms of"/>
  <result pre="anti-desmocollin reactivity is only recommended in patients with IgA pemphigus," exact="pemphigus" post="vegetans, atypical pemphigus, and the rare patients with pemphigus"/>
  <result pre="pemphigus, pemphigus vegetans, atypical pemphigus, and the rare patients with" exact="pemphigus" post="vulgaris/foliaceus without anti-Dsg reactivity ( 36). Most recently, a"/>
  <result pre="dermis. Sera from a patient with anti-p200/laminin γ1 pemphigoid and" exact="epidermolysis bullosa" post="acquisita (EBA), respectively, showed IgG4 reactivity against the p200"/>
  <result pre="conditioned medium of cultured human keratinocytes. Sera from patients with" exact="bullous pemphigoid" post="(BP), mucous membrane pemphigoid (MMP), both without BP180 NC16A"/>
  <result pre="clinical and immunopathological characteristics of major AIBD Pemphigus vulgaris and" exact="pemphigus" post="foliaceus Pemphigus can be divided in two major clinical"/>
  <result pre="in two major clinical subtypes, PV and PF. Autoantibodies in" exact="pemphigus" post="are directed against epidermal desmosomes, mainly desmoglein (Dsg) 1"/>
  <result pre="sign moderately sensitive, but highly specific in the diagnosis of" exact="pemphigus" post="( 89). PF is clinically characterized by flaccid, superficial"/>
  <result pre="be used as disease activity marker ( 30, 46). Paraneoplastic" exact="pemphigus" post="Paraneoplastic pemphigus (PNP) is an AIBD that is characterized"/>
  <result pre="as disease activity marker ( 30, 46). Paraneoplastic pemphigus Paraneoplastic" exact="pemphigus" post="(PNP) is an AIBD that is characterized by its"/>
  <result pre="The most frequently associated neoplasms are B-cell lymphoma, Castleman disease," exact="chronic lymphocytic leukemia," post="thymoma, and Waldenstrom macroglobulinemia ( 84, 93, 94). The"/>
  <result pre="B-cell lymphoma, Castleman disease, chronic lymphocytic leukemia, thymoma, and Waldenstrom" exact="macroglobulinemia" post="( 84, 93, 94). The clinical phenotype is diverse."/>
  <result pre="mucous membrane involvement ( 95). Furthermore, pulmonary destruction leading to" exact="bronchiolitis" post="obliterans was noticed in many PNP-patients ( 98). Apart"/>
  <result pre="more frequent compared to BP and a high association with" exact="psoriasis" post="is seen in Japanese patients with anti-laminin 332 pemphigoid"/>
  <result pre="149, 152, 156, 157). Dermatitis herpetiformis Dermatitis herpetiformis is an" exact="autoimmune disease" post="that always occurs in combination with glutensensitive enteropathy (celiac"/>
  <result pre="an autoimmune disease that always occurs in combination with glutensensitive" exact="enteropathy" post="(celiac disease). It is clinically characterized by grouped vesicles"/>
  <result pre="PP Hunziker T Trüeb RM et al. . Incidence of" exact="bullous pemphigoid" post="and pemphigus in Switzerland: a 2-year prospective study ."/>
  <result pre="Trüeb RM et al. . Incidence of bullous pemphigoid and" exact="pemphigus" post="in Switzerland: a 2-year prospective study . Br J"/>
  <result pre="C Duvert-Lehembre S et al. . Incidence and mortality of" exact="bullous pemphigoid" post="in France. J Invest Dermatol. ( 2012) 132: 1998–"/>
  <result pre="Jokelainen J Timonen M Tasanen K . Increasing incidence of" exact="bullous pemphigoid" post="in Northern Finland: a retrospective database study in Oulu"/>
  <result pre="Fleming KM Smith CJP West J . Bullous pemphigoid and" exact="pemphigus" post="vulgaris–incidence and mortality in the UK: population based cohort"/>
  <result pre="K Seifert O Nilzén K Grönhagen C . Incidence of" exact="bullous pemphigoid" post="in Sweden 2005-2012: a nationwide population-based cohort study of"/>
  <result pre="Silverberg JI . Hospitalization, inpatient burden and comorbidities associated with" exact="bullous pemphigoid" post="in the U.S.A . Br J Dermatol. ( 2017)"/>
  <result pre="Nouira R Jomaa B et al. . Comparative epidemiology of" exact="pemphigus" post="in Tunisia and France: unusual incidence of pemphigus foliaceus"/>
  <result pre="epidemiology of pemphigus in Tunisia and France: unusual incidence of" exact="pemphigus" post="foliaceus in young Tunisian women . J Invest Dermatol."/>
  <result pre="D Aoki V Filhio GH et al. . Advances in" exact="pemphigus" post="and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a"/>
  <result pre="GH et al. . Advances in pemphigus and its endemic" exact="pemphigus" post="foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity"/>
  <result pre="Linder R Schmidt E . Prevalence and age distribution of" exact="pemphigus" post="and pemphigoid diseases in Germany. J Invest Dermatol. ("/>
  <result pre="Jordon RE . Demonstration of skin antibodies in sera of" exact="pemphigus" post="vulgaris patients by indirect immunofluorescent staining . Proc Soc"/>
  <result pre="G Hale WL Lever WF . Basement zone antibodies in" exact="bullous pemphigoid." post="JAMA ( 1967) 200: 751– 6. 4164640 23. Mihai"/>
  <result pre="RS Voorhees JJ Beals TF Diaz LA . Induction of" exact="pemphigus" post="in neonatal mice by passive transfer of IgG from"/>
  <result pre="et al. . A passive transfer model of the organ-specific" exact="autoimmune disease," post="bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen,"/>
  <result pre=". A passive transfer model of the organ-specific autoimmune disease," exact="bullous pemphigoid," post="using antibodies generated against the hemidesmosomal antigen, BP180 ."/>
  <result pre="Lazarova Z Hsu R Yee C Yancey KB . Antiepiligrin" exact="cicatricial pemphigoid" post="represents an autoimmune response to subunits present in laminin"/>
  <result pre="mediate tissue destruction in a novel adult mouse model of" exact="bullous pemphigoid" post=". Am J Pathol. ( 2014) 184: 2185– 96."/>
  <result pre="drug-targets for personalized treatment of autoimmune disorders-what we learn from" exact="epidermolysis bullosa" post="acquisita . Expert Opin Ther Targets ( 2016) 20:"/>
  <result pre="autoantibodies to BP180 requires innate immune players in a humanized" exact="bullous pemphigoid" post="mouse model . J Autoimmun. ( 2008) 31: 331–"/>
  <result pre="R et al. . S2k guideline for the diagnosis of" exact="pemphigus" post="vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges. ("/>
  <result pre=". S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and" exact="bullous pemphigoid." post="J Dtsch Dermatol Ges. ( 2015) 13: 713– 27."/>
  <result pre="Meijer HJ et al. . Serration pattern analysis for differentiating" exact="epidermolysis bullosa" post="acquisita from other pemphigoid diseases . J Am Acad"/>
  <result pre=". Comparative study of direct and indirect immunofluorescence and of" exact="bullous pemphigoid" post="180 and 230 enzyme-linked immunosorbent assays for diagnosis of"/>
  <result pre="pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of" exact="bullous pemphigoid" post=". J Am Acad Dermatol. ( 2013) 69: 748–"/>
  <result pre="(monkey oesophagus and normal human skin) in the diagnosis of" exact="pemphigus" post=". Australas J Dermatol. ( 2005) 46: 239– 41."/>
  <result pre="improve the sensitivity of indirect immunofluorescence in the diagnosis of" exact="pemphigus" post=". Br J Dermatol. ( 2000) 142: 1135– 9."/>
  <result pre="Gaucherand M Thivolet J Nicolas JF . Serological diagnosis of" exact="bullous pemphigoid" post="(BP): comparison of the sensitivity of indirect immunofluorescence on"/>
  <result pre="correlation of disease activity with serum autoantibody levels in individual" exact="pemphigus" post="patients . Exp Dermatol. ( 2010) 19: 458– 63."/>
  <result pre="recombinant NC16a protein as a diagnostic and monitoring tool for" exact="bullous pemphigoid" post=". J Dermatol Sci. ( 2002) 30: 224– 32."/>
  <result pre="recombinant proteins of human BP230 as a diagnostic tool for" exact="bullous pemphigoid" post=". J Dermatol Sci. ( 2006) 41: 21– 30."/>
  <result pre=". Sensitive and specific assays for routine serological diagnosis of" exact="epidermolysis bullosa" post="acquisita . J Am Acad Dermatol. ( 2013) 68:"/>
  <result pre="for the diagnosis and analysis of the time course of" exact="epidermolysis bullosa" post="acquisita patients . J Dermatol Sci. ( 2011) 62:"/>
  <result pre="leading to a novel enzyme-linked immunosorbent assay for autoantibodies in" exact="bullous pemphigoid" post=". Br J Dermatol ( 2012) 166: 964– 970."/>
  <result pre="et al. . Enzyme-linked immunosorbent assay for the combination of" exact="bullous pemphigoid" post="antigens 1 and 2 in the diagnosis of bullous"/>
  <result pre="bullous pemphigoid antigens 1 and 2 in the diagnosis of" exact="bullous pemphigoid" post=". Arch Dermatol. ( 2011) 147: 293– 8. 10.1001/archdermatol.2011.21"/>
  <result pre="A Gamou S et al. . Characterization of autoantibodies in" exact="pemphigus" post="using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins"/>
  <result pre="SJ Black MM . The severity of cutaneous and oral" exact="pemphigus" post="is related to desmoglein 1 and 3 antibody levels"/>
  <result pre="specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic" exact="pemphigus" post=". Clin Chim Acta ( 2009) 410: 13– 8."/>
  <result pre="et al Novel assay for detecting celiac disease-associated autoantibodies in" exact="dermatitis" post="herpetiformis using deamidated gliadin-analogous fusion peptides J Am Acad"/>
  <result pre="et al. . Autoantibody Profile Differentiates between Inflammatory and noninflammatory" exact="bullous pemphigoid" post=". J Invest Dermatol. ( 2016) 136: 2201– 10."/>
  <result pre=". Detection of laminin 5-specific auto-antibodies in mucous membrane and" exact="bullous pemphigoid" post="sera by ELISA . J Invest Dermatol. ( 2005)"/>
  <result pre="BP180 and BP230 and their relationship to clinical features in" exact="bullous pemphigoid" post=". Br J Dermatol. ( 2017) 177: 141– 51."/>
  <result pre="Correlation of serum levels of IgE autoantibodies against BP180 with" exact="bullous pemphigoid" post="disease activity . JAMA Dermatol. ( 2017) 153: 30–"/>
  <result pre="novel ELISA reveals high frequencies of BP180-specific IgE production in" exact="bullous pemphigoid" post=". J Immunol Methods ( 2009) 346: 18– 25."/>
  <result pre=". Multicenter prospective study of the humoral autoimmune response in" exact="bullous pemphigoid." post="Clin Immunol. ( 2008) 128: 415– 26. 10.1016/j.clim.2008.04.012 18571472"/>
  <result pre="C Stauber A et al. . Severity and phenotype of" exact="bullous pemphigoid" post="relate to autoantibody profile against the NH2- and COOH-terminal"/>
  <result pre=". New biochip immunofluorescence test for the serological diagnosis of" exact="pemphigus" post="vulgaris and foliaceus: a review of the literature ."/>
  <result pre="use of Biochip immunofluorescence microscopy for the serological diagnosis of" exact="epidermolysis bullosa" post="acquisita . Arch Dermatol Res. ( 2016) 308: 273–"/>
  <result pre="serum antidesmocollin autoantibodies is only useful in patients with atypical" exact="pemphigus" post=". Exp Dermatol. ( 2017) 26: 1267– 70. 10.1111/exd.13409"/>
  <result pre="Culton DA Diaz LA . Diagnosis and clinical features of" exact="pemphigus" post="foliaceus. Dermatol Clin. ( 2011) 29: 405– 12. 10.1016/j.det.2011.03.012"/>
  <result pre="desmoglein I binds the same polypeptide as human autoantibodies in" exact="pemphigus" post="foliaceus . J Immunol. ( 1986) 136: 1227– 30."/>
  <result pre="Salem R Boulos F Habib K Tfayli A . Paraneoplastic" exact="pemphigus" post="as a first manifestation of an intra-abdominal follicular dendritic"/>
  <result pre="Dwilewicz-Trojaczek J Wozniak K Hashimoto T Kowalewski C . Paraneoplastic" exact="pemphigus" post="with anti-desmocollin 3 autoantibodies and chronic lymphocytic leukemia ."/>
  <result pre="Kowalewski C . Paraneoplastic pemphigus with anti-desmocollin 3 autoantibodies and" exact="chronic lymphocytic leukemia" post=". Adv Dermatol Allergol. ( 2018) 35: 113– 5."/>
  <result pre=". Paraneoplastic pemphigus with anti-desmocollin 3 autoantibodies and chronic lymphocytic" exact="leukemia" post=". Adv Dermatol Allergol. ( 2018) 35: 113– 5."/>
  <result pre="29599682 98. Nikolskaia OV Nousari CH Anhalt GJ . Paraneoplastic" exact="pemphigus" post="in association with Castleman's disease. Br J Dermatol. ("/>
  <result pre="T Takeda Y et al. . Epiplakin is a paraneoplastic" exact="pemphigus" post="autoantigen and related to bronchiolitis obliterans in Japanese patients"/>
  <result pre=". Epiplakin is a paraneoplastic pemphigus autoantigen and related to" exact="bronchiolitis" post="obliterans in Japanese patients . J Invest Dermatol. ("/>
  <result pre="protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic" exact="pemphigus" post="autoantibodies in human . PLoS ONE ( 2010) 5:"/>
  <result pre="linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic" exact="pemphigus" post="patients . J Invest Dermatol. ( 2006) 126: 832–"/>
  <result pre="Watt FM Salmhofer W Kanzaki T Hashimoto T . Paraneoplastic" exact="pemphigus" post="sera react strongly with multiple epitopes on the various"/>
  <result pre="P Yuspa SH Shevach EM Katz SI . Characterization of" exact="bullous pemphigoid" post="antigen: a unique basement membrane protein of stratified squamous"/>
  <result pre="EB Zillikens D . Immunopathologic changes in 115 patients with" exact="bullous pemphigoid." post="Hautarzt Z Dermatol Venerol Verwandte Geb. ( 1999) 50:"/>
  <result pre="R Borradori L . Clinical features and practical diagnosis of" exact="bullous pemphigoid." post="Dermatol Clin. ( 2011) 29: 427– 38. 10.1016/j.det.2011.03.010 21605808"/>
  <result pre="Barbe C Pham B-N et al. . Mucosal involvement in" exact="bullous pemphigoid" post="is mostly associated with disease severity and to absence"/>
  <result pre="Diaz LA . Cloning and primary structural analysis of the" exact="bullous pemphigoid" post="autoantigen BP180. J Invest Dermatol. ( 1992) 99: 243–"/>
  <result pre="al. . Tight clustering of extracellular BP180 epitopes recognized by" exact="bullous pemphigoid" post="autoantibodies . J Invest Dermatol. ( 1997) 109: 573–"/>
  <result pre="autoantibodies to BP180 correlate with disease activity in patients with" exact="bullous pemphigoid" post=". Arch Dermatol. ( 2000) 136: 174– 8. 10.1001/archderm.136.2.174"/>
  <result pre="of the anti-BP180 autoantibody reactivity profile and epitope mapping in" exact="bullous pemphigoid" post="patients . J Invest Dermatol. ( 2004) 122: 103–"/>
  <result pre="C Arndt R Christophers E et al. . Patients with" exact="bullous pemphigoid" post="and linear IgA disease show a dual IgA and"/>
  <result pre="Schulze FS Zillikens D Schmidt E . IgE-mediated mechanisms in" exact="bullous pemphigoid" post="and other autoimmune bullous diseases. Expert Rev Clin Immunol."/>
  <result pre="Schumann H Bruckner-Tuderman L et al. . IgG autoantibodies from" exact="bullous pemphigoid" post="patients recognize multiple antigenic reactive sites located predominantly within"/>
  <result pre="NC16A IgG but not with anti-BP230 IgG in patients with" exact="bullous pemphigoid" post=". Arch Dermatol Res. ( 2018) 310: 255– 9."/>
  <result pre="autoantibodies target epitopes on both intra- and extracellular domains of" exact="bullous pemphigoid" post="antigen 180 . Br J Dermatol. ( 2001) 145:"/>
  <result pre="Yancey KB . Anti-basement membrane autoantibodies in patients with anti-epiligrin" exact="cicatricial pemphigoid" post="bind the alpha subunit of laminin 5 . J"/>
  <result pre="Darling TN Yee C Coté T Yancey KB . Anti-epiligrin" exact="cicatricial pemphigoid" post="and relative risk for cancer. Lancet Lond Engl. ("/>
  <result pre="a portion of the extracellular domain of the 180 kDa" exact="bullous pemphigoid" post="antigen, BPAg2 . J Invest Dermatol. ( 1998) 110:"/>
  <result pre=". International bullous diseases group: consensus on diagnostic criteria for" exact="epidermolysis bullosa" post="acquisita . Br J Dermatol. ( 2017) 179: 30–"/>
  <result pre="Gammon WR . Identification of the skin basement-membrane autoantigen in" exact="epidermolysis bullosa" post="acquisita . N Engl J Med. ( 1984) 310:"/>
  <result pre="Ludwig RJ Schmidt E . Clinical features and diagnosis of" exact="epidermolysis bullosa" post="acquisita. Expert Rev Clin Immunol. ( 2017) 13: 157–"/>
  <result pre="Ludwig RJ . Clinical presentation, pathogenesis, diagnosis, and treatment of" exact="epidermolysis bullosa" post="acquisita . ISRN Dermatol. ( 2013) 2013: 812029. 10.1155/2013/812029"/>
  <result pre="GFH Pas HH Jonkman MF . The many faces of" exact="epidermolysis bullosa" post="acquisita after serration pattern analysis by direct immunofluorescence microscopy"/>
  <result pre="discrete peptide sequences recognized by sera from patients with acquired" exact="epidermolysis bullosa." post="J Clin Invest. ( 1993) 92: 1831– 9. 10.1172/JCI116774"/>
  <result pre="collagen antibodies detected by enzyme-linked immunosorbent assay in patients with" exact="epidermolysis bullosa" post="acquisita are correlated with the severity of skin lesions"/>
  <result pre="Liu C . Blindness due to the IgA variant of" exact="epidermolysis bullosa" post="acquisita, and treatment with osteo-odonto-keratoprosthesis . Br J Dermatol."/>
  <result pre="RM de Jong MCJM Pas HH Jonkman MF . IgA-mediated" exact="epidermolysis bullosa" post="acquisita: two cases and review of the literature. J"/>
  <result pre="et al. . Newly described clinical and immunopathological feature of" exact="dermatitis" post="herpetiformis. Clin Dev Immunol. ( 2012) 2012: 967974. 10.1155/2012/967974"/>
  <result pre="N . Epidermal transglutaminase (TGase 3) is the autoantigen of" exact="dermatitis" post="herpetiformis. J Exp Med. ( 2002) 195: 747– 757."/>
  <result pre="epidermal transglutaminase are a sensitive diagnostic marker in patients with" exact="dermatitis" post="herpetiformis on a normal or gluten-free diet . J"/>
 </snippets>
</snippetsTree>
